Legislation

Hi Chapter Presidents – Hope all is well. US Senators Markey and Paul (as well as their House counterparts) plan to introduce – soon – the portions of the Opioid Treatment Access Act (OTAA) from the last Congress that didn’t make it into the Consolidated Appropriations Act, 2023. Attached is that draft legislation. In brief, this legislation, now named the “Modernizing Opioid...

Good Morning, ASAM Chapter Presidents and Advocacy Leaders: SAMHSA has recently posted the following message on its website: Congress has taken action in the recent Consolidated Appropriations Act, 2023 that impacts federal requirements for Drug Enforcement Administration (DEA) registrants, including those involved in OUD treatment. SAMHSA and DEA are actively working to develop further...

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver applications). All...

Dear Registrants: On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA Waiver Program.” DEA fully supports this significant policy reform. ln this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing...

Good Evening – I bring good news. One thing ASAM was not able to achieve – which had been on our legislative agenda – during our Addiction Medicine Advocacy Conference last year – was the passage of the Medicaid Reentry Act, which would have allowed for Medicaid coverage for eligible individuals – who were incarcerated – up to 30 days prior to their release....

ASAM Praises Congress for Passing Vital Provisions in End-of-Year Legislation that Will Increase Access to Addiction Care and Save Lives Nation’s leading association of addiction medicine physicians and other clinicians commend the inclusion of provisions to expand access to addiction care in the Consolidated Appropriations Act, 2023 Rockville, MD – The American Society of Addiction Medicine...

Public Policy Statement on the Regulation of the Treatment of Opioid Use Disorder with Methadone Excerpt: The treatment of opioid use disorder (OUD) with methadone has a long history and robust scientific evidence supporting its effectiveness. Currently, U.S. federal law limits its availability to certified, accredited, and heavily regulated opioid treatment programs (OTPs), a...

A July law could lock up new mothers who are on drugs, a move that some say will inflict even more harm September 30, 2014 5:00AM ET by Lindsay Beyerstein@Beyerstein Excerpt: In theory, a woman who gives birth to a sick baby could avoid the misdemeanor-assault charge that SB1391 carries by successfully completing a court-approved drug-rehab program. But for a number of reasons, including...

Legislative Draft for the Consolidated Appropriations Act, 2023

Congress Takes Action Which Impacts Federal Requirements for DEA Registrants

NEW SAMHSA MESSAGE ON CONSOLIDATED APPROPRIATIONS ACT, 2023

Bye-bye X-Waiver

Critical Pre-release Services for Incarcerated Individuals

ASAM Praises Congress for Passing Vital Provisions in End-of-Year Legislation that Will Increase Access to Addiction Care and Save Lives

ASAM’s Public Policy Statement on Regulation of Opioid Use Disorder Treatment

SB1391- Bad Medicine in Tennessee for Pregnant and Drug-addicted Women

The Georgia Society of Addiction Medicine